Posaconazole

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4012 publications

Multicenter Study Reveals Alarming Terbinafine Resistance in Trichophyton indotineae Isolates from Iran.

Multicenter Study Reveals Alarming Terbinafine Resistance in Trichophyton indotineae Isolates from Iran.

Journal: Medical mycology
Published: June 22, 2026

Management of Acute Myeloid Leukemia in a Dialysis-Dependent Patient: A Case Report, Literature Review, and Therapeutic Considerations.

Management of Acute Myeloid Leukemia in a Dialysis-Dependent Patient: A Case Report, Literature Review, and Therapeutic Considerations.

Journal: Cureus
Published: June 12, 2026

From anti-fungal to potential neurotherapeutic: Posaconazole as an effective inhibitor of cellular TDP-43 pathology.

From anti-fungal to potential neurotherapeutic: Posaconazole as an effective inhibitor of cellular TDP-43 pathology.

Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026

A long non-coding RNA, afu-254, is required for the oxidative stress response, cell wall stress response, azole susceptibility, and virulence in Aspergillus fumigatus.

A long non-coding RNA, afu-254, is required for the oxidative stress response, cell wall stress response, azole susceptibility, and virulence in Aspergillus fumigatus.

Journal: mSphere
Published: June 09, 2026

CYP51C Y319H and H349R substitutions cannot confer azole resistance in Aspergillus flavus NRRL 3357-5.

CYP51C Y319H and H349R substitutions cannot confer azole resistance in Aspergillus flavus NRRL 3357-5.

Journal: Microbiology spectrum
Published: June 09, 2026

Crushed posaconazole delayed-release tablets via enteric feeding tube administration: practical considerations for clinicians.

Crushed posaconazole delayed-release tablets via enteric feeding tube administration: practical considerations for clinicians.

Journal: The Journal of antimicrobial chemotherapy
Published: June 08, 2026

Manogepix demonstrates potent in vitro activity against Aspergillus, Coccidioides, Scopulariopsis/Microascus, Rasamsonia, and Purpureocillium species, including strains with in vitro resistance to other antifungals.

Manogepix demonstrates potent in vitro activity against Aspergillus, Coccidioides, Scopulariopsis/Microascus, Rasamsonia, and Purpureocillium species, including strains with in vitro resistance to other antifungals.

Journal: Antimicrobial agents and chemotherapy
Published: June 04, 2026

STAT3 gene-related hyper-IgE syndrome complicated by pulmonary aspergillosis: a case report

STAT3 gene-related hyper-IgE syndrome complicated by pulmonary aspergillosis: a case report

Journal: Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases
Published: June 03, 2026

The black aspergilli (Aspergillus niger complex) and their role in human, animal, and plant diseases.

The black aspergilli (Aspergillus niger complex) and their role in human, animal, and plant diseases.

Journal: Clinical microbiology reviews
Published: June 02, 2026

In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025.

In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025.

Journal: Emerging infectious diseases
Published: June 02, 2026

Post-SARS CoV-2 infection laryngeal mucormycosis: a rare ail mimicking malignancy.

Post-SARS CoV-2 infection laryngeal mucormycosis: a rare ail mimicking malignancy.

Journal: BMJ case reports
Published: May 29, 2026

Candidozyma auris susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents.

Candidozyma auris susceptibility from Michigan hospitals to manogepix, rezafungin and nine other antifungal agents.

Journal: JAC-antimicrobial resistance
Published: May 29, 2026
Showing 1-12 of 4,012

Last Updated: 06/30/2026